Biognosys AG
Schlieren, ZH
- UEI
- HDXNJKX5E4Y3
- CAGE
- SBQW4
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- International Organization
- SAM.gov registration date
- Physical address
- Wagistrasse 21, 8952 Schlieren, Switzerland
- Website
- biognosys.com
- Founded
- 2008
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $16,744 |
| FY2023 | $77,076 |
Contract awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Pelago Bioscience AB | Stockholms län | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Applied Biomics, Inc. | Hayward, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Tecan Genomics, Inc. | Morgan Hill, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Antibodies-Online Inc. | Royersford, PA | 325414 Biological Product (except Diagnostic) Manufacturing |
| Ampseq LLC | Gaithersburg, MD | 541380 Testing Laboratories and Services |
About the company
Biognosys AG is an international, for-profit organization registered in SAM.gov since August 24, 2016, with registration valid through August 20, 2025. The company specializes in advanced proteomics services, offering sophisticated scientific research and laboratory analysis capabilities to federal agencies. While specific details about the company's full organizational background are not provided in the contract award documentation, the federal contract history indicates that Biognosys AG is a Switzerland-based scientific research and services organization with expertise in protein analysis and advanced laboratory techniques.
The company has secured multiple federal contract awards primarily from civilian agencies, specifically the National Institute of Child Health and Human Development (NICHD), demonstrating specialized capabilities in proteome profiling and advanced scientific services. These contracts, valued between approximately $15,000 and $62,000, involve complex laboratory research services such as proteomic analysis of human plasma samples, lab sample profiling, and specialized protein expression pattern analysis for rare disease research. The contracts are consistently structured as purchase orders with firm fixed pricing, and none of the awards have been designated as set-aside contracts. The most recent award, dated August 5, 2024, is a $16,744 contract for lab sample profiling, with performance occurring in Switzerland, highlighting the company's international capacity to provide specialized scientific services to U.S. federal research agencies.
Quick answers
Is Biognosys AG registered in SAM.gov?
Yes. Biognosys AG's SAM.gov registration is active through March 4, 2027.
What is Biognosys AG's CAGE code?
Biognosys AG's CAGE code is SBQW4, and its Unique Entity ID (UEI) is HDXNJKX5E4Y3.
How much has Biognosys AG received in federal contracts?
Federal contracts obligated $93,820 to Biognosys AG in fiscal years 2023 through 2027.
What is Biognosys AG's most recent federal award?
Biognosys AG's most recent federal contract award is Nichd services: lab sample profiling (75N94024P00512), from National Institute of Child Health and Human Development (NIH), on August 5, 2024.
On GovTribe
See Biognosys AG's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors